Project Grant K22CA285820
Award Date
9/1/24
Completion Date
8/31/27
Dollars Obligated
$190K
Federal Agency
National Cancer Institute
Awardee
Duke University (TP7EK8DZV6N5)
Federal Grant Program
93.398
Assistance Type
Project Grant
Place of Performance
Durham, NC 27710, USA
Similar Awards
The National Cancer Institute (NCI) awarded a 5-year, $659,498 Project Grant (CFDA 93.396 - Cancer Biology Research) to Emory University to study racial disparities in the mechanisms of prostate cancer metastasis. The research aims to analyze differential pathway activity, particularly in the oxidative phosphorylation (OXPHOS) pathway and FGFR3 signaling, between African American and European American prostate cancer patients and understand their impact on metastasis. The project will utilize...
This federal Project Grant award, valued at $936,746 and funded by the National Cancer Institute (NCI) under the Cancer Biology Research program (CFDA 93.396), supports research at Rutgers, The State University of New Jersey to investigate the role of mitochondrial stress responses in ovarian cancer and their impact on antitumor immunity. The project aims to characterize the biology of the BTLP3A gene and how its dysfunction promotes accumulation of damaged mitochondria, triggering...
This federal Project Grant award from the National Cancer Institute (CFDA 93.396 Cancer Biology Research) provides $150,271 to the University of Maryland Baltimore County (UMBC) to investigate the role of the protein kinase ADCK5 in ovarian cancer. The 2-year project, which began on September 20, 2023, aims to gain fundamental insights into the mechanisms underlying ovarian cancer, the most lethal gynecologic malignancy in the United States. The research seeks to identify potential new...
This federal Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) provides $660,742 to The University of Texas MD Anderson Cancer Center to conduct research aimed at "Targeting Tumoral Lactobacillus iners to Improve Outcomes in Cervical Cancers." The 5-year project, beginning July 1, 2024, will investigate how the bacteria Lactobacillus iners in cervical tumors influences cancer cell and immune cell metabolism, and test novel therapeutic...
This $362,050 Project Grant award from the National Cancer Institute (NCI), under the Cancer Cause and Prevention Research (CFDA 93.393) program, will fund a study by the University of Alabama at Birmingham (UAB) to investigate the genomic and transcriptomic differences between pancreatic cancer tumors in African American and Caucasian patients. The study aims to better understand the potential molecular mechanisms underlying the disparities in pancreatic cancer incidence and outcomes between...
The National Cancer Institute (NCI) awarded a $368,070 Project Grant (CFDA 93.393 - Cancer Cause and Prevention Research) to Trustees of Boston University to identify and address barriers in the cervical cancer treatment cascade among women with HIV in South Africa. The formative work is intended to develop a multi-level retention care intervention tailored to the unique needs of this population, who are at disproportionate risk for cervical cancer development. The project will conduct...
This $594,823 Project Grant award from the National Cancer Institute (NCI) under the 21st Century Cures Act - Beau Biden Cancer Moonshot program (CFDA 93.353) will fund research to investigate the role of social determinants of health, particularly structural racism and socioeconomic factors, on cardiovascular disease (CVD) outcomes among Black and White cancer survivors.
The project involves leveraging data from the Reasons for Geographic and Racial Disparities in Stroke (REGARDS) study and...
This Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) provides $539,633 to the Albert Einstein College of Medicine to conduct research on aberrant androgen signaling pathways in African American prostate cancer. The research aims to directly address the racial disparity in prostate cancer incidence and mortality between African American and Caucasian American men by examining the oncogenic role and molecular mechanisms of androgen receptor...
This federal Project Grant award from the National Cancer Institute (NCI), under the Cancer Treatment Research program (CFDA 93.395), supports research to determine the role of the gut-breast axis and gut microbiome in breast cancer pathophysiology. Specifically, the $620,959 award, effective from April 5, 2024 through March 31, 2026, aims to investigate whether the gut microbiomes of mice susceptible or resistant to HER2-positive mammary tumors exert pro-tumor or anti-tumor effects, and...
This federal Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) provides $477,869.00 to the University of Texas at Arlington to develop tailored, multilevel cervical cancer interventions for ethnically diverse Black women. The project, which runs from September 1, 2024 to August 31, 2027, aims to:
Identify multilevel determinants of routine cervical cancer screening and follow-up adherence among African American women and Black African immigrant...